Home Tags Cannabis
cannabis Related Content
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group shares a perspective on the present status and potential evolution when it comes to cannabinoids for therapeutic purposes.
Ethnopharm is a key resource for cannabis products and services in the healthcare and Nutraceutical sectors, offering a wide range of services.
CBDepot supply cannabinoid ingredients in forms of isolated substances, whole plant extracts and compounded preparations for the industrial and B2B markets.
DR WATSON manufactures premium CBD products, focussed on delivering only the highest quality andmost effective GMP-certified CBD products in the world.
Here we provide a brief introduction to the medical benefits of CBD and medical Cannabis, with an overview of treatments that have been implemented.
The Academy of Medical Cannabis is focused is on educating doctors, and ongoing development of specialised learning on the subject of medical cannabis.
Research reveals Londoners are the most anxious and have the worst work-life balance in the UK and many would choose to use CBD oil rather than seeing their GP.
A five-year license has been issued to two companies allowing the cultivation and processing of medical cannabis products.
Our mission is to create an environment where individuals can source premium quality health products, such as CW CBD Oil, with confidence.
Eos Scientific has commissioned research across a sample of more than 2000 UK adults exploring the growing shift in health-conscious millennials seeking CBD oil over prescriptions for mental health.
From the stories appearing about CBD and its near miraculous effects, to the pharmaceutical companies rushing to catch up, it seems everyone is taking about cannabidiol.
Snoring? Dry skin? Sleeplessness? Eczema? Inflammation? Studies continue to explore the benefits of CBD oil, the cannabis plant extract.
More than a fifth of Brits say they work more than 50 hours a week in high-stress careers, leading to an increase in cases of anxiety and depression.
Ramya Sriram, manager at Kolabtree, explains why many patients in the UK still cannot access medical cannabis and how scientific communication and further research can lead to change.
Dennis R. Carty, Ph.D. and Pamela J. Lein, Ph.D., University of California, highlight the rising trend of marijuana use during pregnancy and the implications surrounding it.
Oxford Cannabinoid Technologies is a biopharmaceutical company combining cannabinoid medicine with world class scientific research and drug development.
Dr Mark Ware, Chief Medical Officer at Canopy Growth, provides an overview of the research that already exists around medicinal cannabis and explains why there is a need to educate clinicians further.
European Cannabis Holdings (ECH) has announced plans to open The Medical Cannabis Clinics in a step toward aiding patients living with a range of chronic conditions.
A survey by Rehab 4 Addiction using Facebook reveals more than 80% of people aged 55+ are contemplating asking their doctor about medicinal cannabis following the upcoming the change that’s due to kick in next week
Home secretary, Sajid Javid has announced that medicinal products that derive from cannabis will be made available on prescription by Autumn.
12Page 1 of 2